BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20429318)

  • 1. Real-life experiences in migraine therapy.
    Turcani P; Farkasova D; Marcek T; Turcani M
    Bratisl Lek Listy; 2010; 111(2):74-8. PubMed ID: 20429318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care.
    Nett RB; Tiseo PJ; Almas M; Sikes CR
    Int J Clin Pract; 2007 Oct; 61(10):1677-85. PubMed ID: 17877653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs.
    Chia YC; Lim SH; Wang SJ; Cheong YM; Denaro J; Hettiarachchi J
    Headache; 2003 Oct; 43(9):984-90. PubMed ID: 14511275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.
    Landy SH; Tepper SJ; Schweizer E; Almas M; Ramos E
    Cephalalgia; 2014 Apr; 34(5):376-81. PubMed ID: 24265285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.
    Diamond ML; Hettiarachchi J; Hilliard B; Sands G; Nett R
    Headache; 2004 Mar; 44(3):209-16. PubMed ID: 15012657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.
    Mathew NT; Schoenen J; Winner P; Muirhead N; Sikes CR
    Headache; 2003 Mar; 43(3):214-22. PubMed ID: 12603639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of eletriptan administration during the aura phase of migraine.
    Olesen J; Diener HC; Schoenen J; Hettiarachchi J
    Eur J Neurol; 2004 Oct; 11(10):671-7. PubMed ID: 15469451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States.
    Sheftell F; Ryan R; Pitman V;
    Headache; 2003 Mar; 43(3):202-13. PubMed ID: 12603638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
    Sunshine A; Mulhern SA; Olson N; Elkind A; Almas M; Sikes C
    Clin Ther; 2006 Aug; 28(8):1107-1115. PubMed ID: 16982287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
    Almas M; Tepper SJ; Landy S; Schweizer E; Ramos E
    Cephalalgia; 2014 Feb; 34(2):126-35. PubMed ID: 23946318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eletriptan review.
    Färkkilä M; Kallela M
    Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
    Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
    Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.